Combined pharmaceutical composition of pyrrolo[2,3-c]pyridone compound and use thereof
Patent Information
- Application Number
- HK62026124877
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-09
- Filing Date
- 2026-06-16
- Publication Date
- 2026-09-11
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480027334.X (22) Application Date 2024.05.08 (66) Domestic Priority Data 202310518474.4 2023.05.09 CN (85) PCT International Application Entering National Phase Date 2025.10.22 (86) PCT International Application Application Data PCT / CN2024 / 091682 2024.05.08 (87) PCT International Application Publication Data WO2024 / 230727 ZH 2024.11.14 (71) Applicant: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Address: 369 Yuzhou South Road, Lianyungang City, Jiangsu Province, 222062, China Inventor No. (72) Inventors: Ding Dawei, Yu Ding, Wang Xunqiang, Zhang Xiquan, Zhao Wei, Lao Shanli (51) Int.Cl. C07D 471 / 04 (2006.01) A61P 35 / 00 (2006.01) A61K 31 / 437 (2006.01) A61K 31 / 519 (2006.01) C07D 487 / 04 (2006.01) (54) Invention Title: A combination pharmaceutical composition of pyrrolo[2,3-c]pyridinone compounds and its use therein (57) Abstract: A combination pharmaceutical composition relating to pyrrolo[2,3-c]pyridinone compounds and its use therein. Specifically, it relates to a combination pharmaceutical composition of compounds of formula (I) and its use in the treatment of myelofibrosis. CN 121285550 A 2026.01.06 CN 1 21 28 55 50 A
